SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-205401
Filing Date
2020-07-31
Accepted
2020-07-31 09:19:59
Documents
5
Period of Report
2020-07-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d45442d8k.htm 8-K 28316
2 EX-4.1 d45442dex41.htm EX-4.1 132680
3 EX-10.1 d45442dex101.htm EX-10.1 183330
4 EX-10.2 d45442dex102.htm EX-10.2 88738
5 EX-10.3 d45442dex103.htm EX-10.3 138832
  Complete submission text file 0001193125-20-205401.txt   573256
Mailing Address 1895 MOUNT HOPE AVE ROCHESTER NY 14620
Business Address 1895 MOUNT HOPE AVE ROCHESTER NY 14620 585-271-2700
VACCINEX, INC. (Filer) CIK: 0001205922 (see all company filings)

IRS No.: 161603202 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38624 | Film No.: 201063950
SIC: 2834 Pharmaceutical Preparations